Xeloda and Breastfeeding

Studies have shown that Xeloda does pass through breast milk in mice, but it is unclear if the medication passes through breast milk in humans. Due to the potentially serious side effects that could occur in the nursing infant, the manufacturer of Xeloda recommends that women not take the medication when breastfeeding. If you are taking Xeloda and breastfeeding at the same time, talk to your healthcare provider about what is best for your situation.

Xeloda and Breastfeeding: An Overview

It is not known if Xeloda® (capecitabine) passes through breast milk. Because of the potentially serious side effects that could occur in the nursing infant, the manufacturer of Xeloda recommends that women not breastfeed while taking Xeloda. Therefore, make sure to let your healthcare provider know if you are breastfeeding or thinking of breastfeeding.
 

Xeloda and Breastfeeding: What Does the Research Say?

Xeloda passes through breast milk in mice, but it is unknown if it passes through breast milk in humans. Because Xeloda can cause serious side effects (see Xeloda Side Effects), most healthcare providers do not recommend taking Xeloda while breastfeeding.
 

Talking With Your Healthcare Provider About Xeloda and Breastfeeding

You should talk with your healthcare provider about Xeloda and breastfeeding. Everyone's situation is different, and your healthcare provider understands your situation best. After considering what you want and expect, as well as your current health situation, you and your healthcare provider can make a shared decision about Xeloda and breastfeeding in your particular situation.
7 Easy Tips for Starting Solids

Xeloda Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.